CAPI Oncology Summit
On the Future of Oncology & Hematology
April 5, 2025 - Orlando, Florida
Caribe Royale Resort - Convention Center
The annual CAPI Oncology & Hematology Summit brings together 30 top oncologists and hematologists from Central Florida to join industry innovators for an intensive learning experience. A strategically crafted invitation-only attendee list blends with a thoughtfully curated program - delivering an inspiring experience to advance attendees in the fields of oncology and hematology. Attendees are selected by a committee to attend, as invited guests conference fees and meals are hosted by CAPI. No CME credit is offered.
aTTENDEES
A total of 30 top Oncologists and Hematologists are selected by a committee to attend. As invited guests conference fees are hosted by CAPI. No CME credit offered at this conference
sponsors
The CAPI Oncology Summit provides a one-day intensive learning canvas, ideal to showcase your unique expertise in the field of oncology and hematology healthcare. Engagement opportunities include designing a speaker session, activating your brand in the exhibitor showcase, and other customized networking experiences.
speakers
The CAPI Oncology Summit is honored to welcome a list of esteemed experts. As a speaker please use the code provided in your agreement to access to the speaker portal to download your speaker kit, upload presentation materials, and access key information about your engagement.
The Program
CAPI Oncology Summit
April 5, 2025
Caribe Royale Resort - Orlando
Sessions Located In: Curaco 1 - 4
Exhibition and Meals Located In: Curaco 5 - 8
Our program is being co-curated by our Session Sponsors, the topics below are place savers and will be updated as session sponsors provide their topic and speaker name.
7:30am 8:00am - Registration and Breakfast
7:55am - 8:00am - Opening Remarks (CAPI Co Chairs)
8:00am - 8:30am - Session 1 - SOBI - Exploring phenotypes in myelofibrosis (MF) and the role of VONJO® (pacritinib) Speaker: Dr. Daniel Landau
8:30am - 9:00am - Session 2 - Immunotherapy Innovations in Solid Tumors and Hematologic Cancers
9:00am - 9:30am - Session 3 - Targeted Therapy in the Management of Myelodysplastic Syndromes and AM
9:30am - 10:00am - Session 4 - Bayer Pharmaceuticals
Exploring the Role of darolutamide in mHSPC in Combination with Docetaxel and in nmCRPC
Speaker: Dr. Daniel Landau
10:00am - 10:30am - Session 5 - Advances in Bone Marrow Transplantation: From Haploidentical to Gene-Edited Grafts
10:30am - 11:00am - Power Break
11:00am - 11:30am - Session 6 - Blueprint Medicines
Understanding AYVAKIT (avapritinib) for Indolent Systemic Mastocytosis(ISM)
Speaker: To be announced
11:30am - 12:00pm - Session 7 - Cardio-Oncology: Managing Cardiovascular Toxicity in Cancer Therapy
12:00pm - 12:30pm - Session 8 - Psycho-Oncology: Integrating Mental Health Support for Cancer Patients
12:30pm - 1:00pm - - Q&A
1:00pm - Lunch